NEMO - an App for Side Effect Management in Oncology

Thomas Seufferlein

Status: Unknown

Conditions: Cancer Patients

Treatments: Other: Documentation of cancer treatment side effects

Study type: Observational

Funder types: Other

Identifiers

NCT04493450

NEMO

Details and patient eligibility

About

This study investigates the use of digital and standardized documentation by patients of frequently occurring adverse events in oncological therapies.

Full description

This research study is structured as a Phase I and II clinical trial. In phase I, the feasibility of using a smartphone application to document adverse events that have occurred during oncological therapies by the patient will be investigated. In phase II we will investigate whether the use of the smartphone app allows an improvement of patient care by reducing occurred adverse events.

Enrollment: 66 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• infusional combination therapy with at least two chemotherapy substances with or without further targeted therapies
• combination of at least two immune-checkpoint inhibitors
• able to read and understand German

Exclusion criteria

Participants who meet any of the following criteria will be excluded:

• severe neurological disorders
• severe psychiatric disorders

Trial design

66 participants in 1 patient group

Smartphone-users

Description:

Cancer patients who use smartphones

Treatment:

Other: Documentation of cancer treatment side effects